Patient characteristics (risk factors for poor outcome)
| Factor . | Incidence (N = 31) . | |
|---|---|---|
| No. . | % . | |
| Stage IV disease | 10 | 32.3 |
| Primary refractory disease* | 10 | 32.3 |
| Extranodal disease | 16 | 51.6 |
| ≥3 lines of previous treatment | 24 | 77.4 |
| Metabolically active disease at transplant | 24 | 77.4 |
| WHO performance status | ||
| 0 | 29 | 93.5 |
| 1 | 2 | 6.5 |
| Factor . | Incidence (N = 31) . | |
|---|---|---|
| No. . | % . | |
| Stage IV disease | 10 | 32.3 |
| Primary refractory disease* | 10 | 32.3 |
| Extranodal disease | 16 | 51.6 |
| ≥3 lines of previous treatment | 24 | 77.4 |
| Metabolically active disease at transplant | 24 | 77.4 |
| WHO performance status | ||
| 0 | 29 | 93.5 |
| 1 | 2 | 6.5 |
Median time from diagnosis to relapse in the cohort of 21 patients with relapsed disease was 10.5 months (range, 3.4-121.9 months).